Corticosteroids not helpful for last-stage acute respiratory distress syndromeAs per new results from the ARDS Clinical Research Network of the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, corticosteroids do not improve survival rate in patients suffering from last-stage ARDS (acute respiratory distress syndrome).

ARDS is a sudden and life-threatening lung condition affecting more than 150,000 people yearly in the United States alone and tend to develop in patients suffering from diseases such as pneumonia or sepsis or major injuries resulting in breathing failure.


Some early benefits to steroid treatment were noted by the involved researchers and these benefits appeared to minimize inflammation in the lungs. In addition to that, the use of steroids does not lead to more secondary infections – a common side effect of steroids.